163 related articles for article (PubMed ID: 34736903)
1. Serum biotin interference: A troublemaker in hormone immunoassays.
Öncül Ü; Eminoğlu FT; Köse E; Doğan Ö; Özsu E; Aycan Z
Clin Biochem; 2022 Jan; 99():97-102. PubMed ID: 34736903
[TBL] [Abstract][Full Text] [Related]
2. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
Piketty ML; Prie D; Sedel F; Bernard D; Hercend C; Chanson P; Souberbielle JC
Clin Chem Lab Med; 2017 May; 55(6):817-825. PubMed ID: 28222020
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Risk for Interference by Circulating Biotin in Samples Received for High Sensitivity Troponin-T, Thyrotropin, and for Prostate Specific Antigen Testing by Immunoassays.
Nguyen KQN; Langevin R; Fankhauser K; Hashim IA
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013345
[TBL] [Abstract][Full Text] [Related]
4. Serum Level of Biotin Rather than the Daily Dosage Is the Main Determinant of Interference on Thyroid Function Assays.
Paketçi A; Köse E; Gürsoy Çalan Ö; Acar S; Teke P; Demirci F; Abacı A; Demir K; Arslan N; Böber E
Horm Res Paediatr; 2019; 92(2):92-98. PubMed ID: 31655813
[TBL] [Abstract][Full Text] [Related]
5. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels.
Valcour A; Blocki F; Hawkins DM; Rao SD
J Clin Endocrinol Metab; 2012 Nov; 97(11):3989-95. PubMed ID: 22933544
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid Glands response to Low Vitamin D levels in Healthy Adults: A Cross-Sectional Study.
Sadat-Ali M; Al-Omran AS; Al-Turki HA
Ulster Med J; 2015 Jan; 84(1):26-9. PubMed ID: 25964700
[TBL] [Abstract][Full Text] [Related]
7. BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS.
Samarasinghe S; Meah F; Singh V; Basit A; Emanuele N; Emanuele MA; Mazhari A; Holmes EW
Endocr Pract; 2017 Aug; 23(8):989-998. PubMed ID: 28534685
[TBL] [Abstract][Full Text] [Related]
8. Biotin supplementation causes erroneous elevations of results in some commercial serum 25-hydroxyvitamin d (25OHD) assays.
Carter GD; Berry J; Cavalier E; Durazo-Arvizu R; Gunter E; Jones G; Jones J; Phinney K; Sempos CT; Twomey PJ; Williams EL
J Steroid Biochem Mol Biol; 2020 Jun; 200():105639. PubMed ID: 32084550
[TBL] [Abstract][Full Text] [Related]
9. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults.
Li D; Radulescu A; Shrestha RT; Root M; Karger AB; Killeen AA; Hodges JS; Fan SL; Ferguson A; Garg U; Sokoll LJ; Burmeister LA
JAMA; 2017 Sep; 318(12):1150-1160. PubMed ID: 28973622
[TBL] [Abstract][Full Text] [Related]
10. [Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases].
Ranaivosoa MK; Ganel S; Agin A; Romain S; Parent X; Reix N
Nephrol Ther; 2017 Dec; 13(7):553-558. PubMed ID: 29133077
[TBL] [Abstract][Full Text] [Related]
11. Interference of anti-streptavidin antibodies: More common than we thought? In relation to six confirmed cases.
Ricci V; Esteban MP; Sand G; Menises MM
Clin Biochem; 2021 Apr; 90():62-65. PubMed ID: 33545112
[TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D, parathyroid hormone, and cardiovascular events among older adults.
Kestenbaum B; Katz R; de Boer I; Hoofnagle A; Sarnak MJ; Shlipak MG; Jenny NS; Siscovick DS
J Am Coll Cardiol; 2011 Sep; 58(14):1433-41. PubMed ID: 21939825
[TBL] [Abstract][Full Text] [Related]
14. Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D.
Farrell CJ; Soldo J; McWhinney B; Bandodkar S; Herrmann M
Clin Chem Lab Med; 2014 Nov; 52(11):1579-87. PubMed ID: 24887958
[TBL] [Abstract][Full Text] [Related]
15. Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays.
Galior KD; Ladwig PM; Snyder MR; Algeciras-Schimnich A; Bornhorst JA; Block DR; Baumann NA; Willrich MAV
Clin Biochem; 2023 Nov; 121-122():110685. PubMed ID: 37972806
[TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis.
Blondon M; Sachs M; Hoofnagle AN; Ix JH; Michos ED; Korcarz C; Gepner AD; Siscovick DS; Kaufman JD; Stein JH; Kestenbaum B; de Boer IH
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2639-45. PubMed ID: 23814117
[TBL] [Abstract][Full Text] [Related]
17. Percentile transformation and recalibration functions allow harmonization of thyroid-stimulating hormone (TSH) immunoassay results.
Padoan A; Clerico A; Zaninotto M; Trenti T; Tozzoli R; Aloe R; Alfano A; Rizzardi S; Dittadi R; Migliardi M; Bagnasco M; Plebani M
Clin Chem Lab Med; 2020 Sep; 58(10):1663-1672. PubMed ID: 31927515
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone response to two levels of vitamin D deficiency is associated with high risk of medical problems during hospitalization in patients with hip fracture.
Alarcón T; González-Montalvo JI; Hoyos R; Diez-Sebastián J; Otero A; Mauleon JL
J Endocrinol Invest; 2015 Oct; 38(10):1129-35. PubMed ID: 26048596
[TBL] [Abstract][Full Text] [Related]
19. Biotin immunoassay interference: A UK-based prevalence study.
Sanders A; Gama R; Ashby H; Mohammed P
Ann Clin Biochem; 2021 Jan; 58(1):66-69. PubMed ID: 32936669
[TBL] [Abstract][Full Text] [Related]
20. Two-site evaluation of the Roche Elecsys Vitamin D total III assay.
Favresse J; Schiettecatte J; Wolff F; Cotton F; Elsen M; Eucher C; Rosseels C; Anckaert E
Clin Chem Lab Med; 2022 Sep; 60(10):1598-1606. PubMed ID: 35849629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
